Go to content
Careers
News & Insights
Contact
Search
Strategy
Toggle submenu
The Acuitas Advantage
Our Partnerships
Our Capabilities
Science
Toggle submenu
Our LNP Technology
Our Clinical Applications
Company
Toggle submenu
About Us
Our Team
Our Community Impact
Home
News
Article
March 10, 2025
PUBLICATION ALERT: Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection